News & Events

Former Head of DARPA is Appointed as Member of UOP Supervisory Board

(Click for full article)

01.02.2018

On the initiative of UKROBORONPROM (UOP), Anthony Tether – former head of the Defense Advanced Research Projects Agency (DARPA) – was appointed as member of UOP  Supervisory Board. This was reported by the press service of the SC”UkrOboronProm”.

Anthony Tether has been in charge of UKROBORONPROM long-term development for over a year and a half. He assists in implementing UOP development strategy, implementation of reforms, corporatization, and international audit. The former head of DARPA contributed to strengthening UKRBORONPROM’s export potential and investment development. Under his chairmanship, the State General Advanced Research and Development Agency (GARDA, the prototype of the American DARPA) was created.

“Almost two years ago, Anthony Tether strengthened our team and introduced American experience of long-term innovation development and management. He is a world-class specialist with international military and management experience. Together, we implemented many large-scale innovation projects and began to actively implement reforms. As a member of the Supervisory Board, Anthony Tether will help UKROBORONPROM to even more effectively implement the reform strategy and international audit,” said Roman Romanov, UKROBORONPROM Director General.

Earlier, Mykhaylo Zhurovs’kyy – the rector of the National Technical University of Ukraine “Kyiv Polytechnic Institute named after I. Sikorsky” – was elected as Chairman of the Supervisory Board. Lieutenant General Yaroslav Skal’ko, former commander-in-chief of the Ukrainian Air Force, was elected as Vice-Chairman.

On January 31, the UKROBORONPROM Supervisory Board – after a long-term meeting -took key decisions on the activities of the Concern. During the meeting, UOP management report was heard; strategic directions for UOP development, corporatization process of UOP enterprises-participants, the international audit, the system of effective anti-corruption measures, creation of an advisory body and other issues were discussed.

 


FDA Announces Comprehensive Regenerative Medicine Policy Framework

(Click for full article)

11.16.2017

Summary: Comprehensive regenerative medicine policy framework to spur innovation, efficient access to potentially transformative products, while ensuring safety & efficacy.